Therefore, the present study investigated the function of DGCR5 in LC and the interaction of DGCR5/miR‐873‐5p/TUSC3 in LC, eventually providing a novel therapeutic target for LC. This evidence concerns the gene DGCR5 and laryngotracheoesophageal cleft.